Conologues: Ultra-fast-acting therapeutic insulins based on cone snail venom insulin principles

Conologues：基于锥蜗牛毒胰岛素原理的超速效治疗性胰岛素

• 批准号: nhmrc : 1143546
• 负责人: A/Pr Briony Forbes
• 金额: $ 73.22万
• 依托单位: The Walter and Eliza Hall Institute of Medical Research
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/conologues-ultra-fast-insulin-principles/1319980
• 关键词: Conologues; Ultra; fast; acting; therapeutic

The increasing prevalence of Type 1 and Type 2 diabetes demands better treatments. Our Project is based on a fascinating discovery by our international team of CIs of a new type of insulin within marine organisms that could form the basis of a novel diabetes therapeutic. Within our Project we will exploit this discovery to develop a new class of ultra-rapid-acting therapeutic insulins.

1型和2型糖尿病的发病率越来越高，需要更好的治疗。我们的项目是基于我们的国际CI团队在海洋生物中发现的一种新型胰岛素的迷人发现，这种发现可能构成新型糖尿病治疗的基础。在我们的项目中，我们将利用这一发现开发一类新的超速效治疗胰岛素。